BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 23831640)

  • 21. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
    Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
    Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
    J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
    Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
    Kamanga-Sollo E; Pampusch MS; White ME; Dayton WR
    J Cell Physiol; 2003 Nov; 197(2):225-31. PubMed ID: 14502562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma.
    Tsubaki M; Yamazoe Y; Yanae M; Satou T; Itoh T; Kaneko J; Kidera Y; Moriyama K; Nishida S
    Cytokine; 2011 Apr; 54(1):100-7. PubMed ID: 21292498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects.
    Schmid C; Ghirlanda-Keller C; Zapf J
    Eur J Endocrinol; 2001 Aug; 145(2):213-21. PubMed ID: 11454519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
    Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism.
    Jeon ES; Moon HJ; Lee MJ; Song HY; Kim YM; Bae YC; Jung JS; Kim JH
    J Cell Sci; 2006 Dec; 119(Pt 23):4994-5005. PubMed ID: 17105765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor-induced activation of the insulin-like growth factor I receptor in rat hepatocytes.
    Hallak H; Moehren G; Tang J; Kaou M; Addas M; Hoek JB; Rubin R
    Hepatology; 2002 Dec; 36(6):1509-18. PubMed ID: 12447877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway.
    Zhang X; Min KW; Liggett J; Baek SJ
    Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
    Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
    Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.